Yanhui Jiang

583 total citations
27 papers, 394 citations indexed

About

Yanhui Jiang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yanhui Jiang has authored 27 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Yanhui Jiang's work include Head and Neck Cancer Studies (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Yanhui Jiang is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Yanhui Jiang collaborates with scholars based in China. Yanhui Jiang's co-authors include Yimin Liu, Xiaohui Zhao, Shangyou Zheng, Zhihua Li, Kaiyun You, Zhuofei Bi, Liting Li, Yuming Luo, Qing Lin and Zhiqiang Fu and has published in prestigious journals such as Cancer Letters, Advances in experimental medicine and biology and Cancer Science.

In The Last Decade

Yanhui Jiang

24 papers receiving 393 citations

Peers

Yanhui Jiang

ONCOL

SURGE

PRM

Lijuan Bian China

Xingsheng Qiu China

Canhui Jin China

Xiaodong Yu China

Yunpeng Jin China

Shi Huirong China

Yifei Ma China

Yunong Fu China

Ning Ning China

Shuoer Wang China

Lijuan Bian China

Yanhui Jiang

157 ×0.6

130 ×0.5

52 ×0.9

ONCOL

46 ×1.2

SURGE

40 ×1.2

PRM

Citations per year, relative to Yanhui Jiang Yanhui Jiang (= 1×) peers Lijuan Bian

Countries citing papers authored by Yanhui Jiang

Since Specialization

Citations

This map shows the geographic impact of Yanhui Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhui Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhui Jiang more than expected).

Fields of papers citing papers by Yanhui Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhui Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhui Jiang. The network helps show where Yanhui Jiang may publish in the future.

Co-authorship network of co-authors of Yanhui Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhui Jiang. A scholar is included among the top collaborators of Yanhui Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhui Jiang. Yanhui Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiao, Min, et al.. (2025). Risk prediction of recurrent ischemic stroke based on Carotid Plaque-RADS: construction and validation of a nomogram model. Frontiers in Aging Neuroscience. 17. 1646916–1646916.

Jiang, Yanhui, et al.. (2024). Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases. Translational Cancer Research. 13(3). 1508–1518. 1 indexed citations

Jiang, Yanhui, et al.. (2024). [Meta-analysis and trial sequential analysis of Tanreqing Injection in treatment of severe pneumonia in elderly].. PubMed. 49(4). 1091–1101. 4 indexed citations

Zhang, Xiaojiao, Yanhui Jiang, Donghua Liu, et al.. (2023). Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy. International Immunopharmacology. 123. 110747–110747. 19 indexed citations

Feng, Yanling, Yang Cai, Dailiang Zhang, et al.. (2023). Association between vaginal microbiota and the progression of ovarian cancer. Journal of Medical Virology. 95(7). e28898–e28898. 10 indexed citations

Huang, Rui, Zhihui Li, Fan Yang, et al.. (2023). Efficacy and safety of PLDR‐IMRT for the re‐irradiation of recurrent NPC: A prospective, single‐arm, multicenter trial. Cancer Science. 114(6). 2534–2543. 1 indexed citations

Wu, Zixuan, et al.. (2022). In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 3 indexed citations

Jiang, Yanhui, Ling Jiang, Wenyan Yu, et al.. (2022). X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer. Frontiers in Genetics. 13. 818917–818917. 2 indexed citations

Jiang, Yanhui, et al.. (2022). [The research progress of PD-1/L1 inhibitors application in the treatment of head and neck squamous cell carcinoma].. PubMed. 36(4). 315–320. 3 indexed citations

10.

Jiang, Yanhui, Jiahui Shen, Yutao Wei, et al.. (2021). DDX19A Promotes Metastasis of Cervical Squamous Cell Carcinoma by Inducing NOX1-Mediated ROS Production. Frontiers in Oncology. 11. 629974–629974. 7 indexed citations

11.

Shen, Jiahui, et al.. (2021). Correlation Analysis Between MTHFR C677T Polymorphism and Uterine Fibroids: A Retrospective Cohort Study. Frontiers in Oncology. 11. 648794–648794. 2 indexed citations

12.

Chen, Changlong, Yanhui Jiang, Shuang Ma, et al.. (2021). BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma. Journal of Cancer. 12(5). 1507–1519. 12 indexed citations

13.

Wu, Jialing, Kaiyun You, Xingsheng Qiu, et al.. (2021). Age as Indicator in the Selection of Surgery Modalities in Early Glottic Cancer. Risk Management and Healthcare Policy. Volume 14. 3223–3231.

14.

Wu, Jialing, Kaiyun You, Yanhui Jiang, et al.. (2021). Prognostic role of pretreatment albumin-to-alkaline phosphatase ratio in locally advanced laryngeal and hypopharyngeal cancer: Retrospective cohort study. Journal of Cancer. 12(20). 6182–6188. 3 indexed citations

15.

You, Kaiyun, et al.. (2019). <p>Selective use of concurrent chemotherapy in elderly cervical cancer patients treated with definitive radiotherapy: experience from two institutions</p>. Cancer Management and Research. Volume 11. 4815–4823. 9 indexed citations

16.

Shen, Ting, et al.. (2019). Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix. Radiation Oncology. 14(1). 203–203. 7 indexed citations

17.

Jiang, Yanhui, et al.. (2017). Tumor volume predicts local recurrence in early rectal cancer treated with radical resection: A retrospective observational study of 270 patients. International Journal of Surgery. 49. 68–73. 21 indexed citations

18.

Jiang, Yanhui, Yimin Liu, & Hai Hu. (2017). Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer. Advances in experimental medicine and biology. 1026. 105–123. 7 indexed citations

19.

Jiang, Yanhui, Zhihua Li, Shangyou Zheng, et al.. (2015). The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1. Tumor Biology. 37(3). 3957–3967. 57 indexed citations

20.

Zheng, Shangyou, Huimou Chen, Yingxue Wang, et al.. (2015). Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner. Cancer Letters. 371(2). 354–365. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact